enhancing life by focussing on cell death

The scope of our technology is what sets us apart in the sphere of life sciences and biomedicine

Apop Biosciences is at the forefront of developing and bringing to market a range of innovative imaging, therapeutic, and diagnostic products based on our proprietary calcitonin receptor antibody technology CalRexin™

 

Apop entered the life sciences market with our proprietary research reagents, the first of which is CalRexin™:568, an antibody conjugated to a fluorophore which detects apoptosis (death) in cells that are cultured. These products have been developed for researchers, biotech and pharma globally who use in vitro assays to study stress and Programmed Cell Death (PCD) related events in live cells.

what we do with CalRexin™

  • Research Reagents

    Apop Biosciences offers proprietary antibody : fluorophore conjugates to scientists for innovative research & understanding of new events in programmed cell death in live cells.

  • Develop Therapeutics

    Apop Biosciences is developing CalRexin™ into a powerful delivery vehicle for drug conjugates to treat refractory tumours, and unmet medical need.

  • Develop Imaging Agents

    We are developing novel CalRexin™ conjugates as diagnostic tools for imaging Programmed Cell Death in patients. Within medicine, this capability is currently unavailable.

Latest News

Apop presents at ACS2023 on further advances with CalRexin®: 647